Close Menu

A Waste of Time?

Pharmaceutical companies have been spending a lot of money on new cancer treatments, but the results have been less than stellar, says Robert Langreth on Forbes' Treatments blog. Pfizer, for example, has been spending a lot of money to develop a cancer drug that, in testing, helps only five percent of lung cancer patients with a particular tumor mutation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.